Bansisons Tea Industries Ltd — Important, 01-06-2026: Company Update

Novyra Pharmachem Limited (formerly Bansisons Tea Industries) has announced its annual financial results for FY26, reporting a loss of Rs. 5.37 crore. To restructure its balance sheet, the company proposes a capital reduction scheme. This involves reducing the paid-up equity capital from Rs. 6.33 crore to Rs. 0.90 crore by canceling 85.71% of existing shares, meaning 1 new share for every 7 held. This will write off accumulated losses of Rs. 5.43 crore, improving financial visibility without any cash outflow to shareholders or affecting creditors. The company also changed its name, relocated its office, and made board appointments during the year.